Mizuho Cuts Ryan Specialty (NYSE:RYAN) Price Target to $44.00

Ryan Specialty (NYSE:RYAN) had its target price reduced by analysts at Mizuho from $53.00 to $44.00 in a research note issued on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Mizuho’s price objective indicates a potential upside of 12.19% from the stock’s current price.

A number of other brokerages have also recently commented on RYAN. Piper Sandler reduced their price target on Ryan Specialty from $58.00 to $43.00 and set a “neutral” rating for the company in a research report on Friday, February 13th. Jefferies Financial Group initiated coverage on shares of Ryan Specialty in a report on Monday, December 1st. They issued a “hold” rating and a $64.00 target price for the company. BMO Capital Markets downgraded shares of Ryan Specialty from an “outperform” rating to a “market perform” rating and lowered their price target for the company from $66.00 to $43.00 in a report on Wednesday. Barclays reduced their price objective on shares of Ryan Specialty from $58.00 to $52.00 and set an “overweight” rating for the company in a research note on Friday, February 13th. Finally, UBS Group lowered their target price on shares of Ryan Specialty from $71.00 to $65.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $56.87.

Ryan Specialty Stock Up 3.3%

Shares of RYAN stock opened at $39.22 on Friday. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 2.62. Ryan Specialty has a 12 month low of $37.29 and a 12 month high of $77.16. The stock has a market cap of $10.36 billion, a P/E ratio of 93.38, a P/E/G ratio of 0.99 and a beta of 0.62. The company has a 50 day simple moving average of $47.66 and a two-hundred day simple moving average of $52.81.

Ryan Specialty (NYSE:RYAN) last issued its quarterly earnings data on Thursday, February 12th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). The business had revenue of $751.21 million for the quarter, compared to the consensus estimate of $777.43 million. Ryan Specialty had a net margin of 7.02% and a return on equity of 46.41%. The company’s revenue was up 13.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.45 EPS. On average, research analysts expect that Ryan Specialty will post 2.29 earnings per share for the current year.

Insider Buying and Selling at Ryan Specialty

In related news, CEO Timothy William Turner sold 129,570 shares of the business’s stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $53.61, for a total value of $6,946,247.70. Following the sale, the chief executive officer directly owned 12,553 shares in the company, valued at approximately $672,966.33. The trade was a 91.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Patrick G. Ryan, Jr. purchased 25,500 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $39.96 per share, with a total value of $1,018,980.00. Following the completion of the purchase, the director owned 428,295 shares of the company’s stock, valued at $17,114,668.20. The trade was a 6.33% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 52.21% of the stock is owned by insiders.

Institutional Trading of Ryan Specialty

Hedge funds have recently modified their holdings of the company. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Ryan Specialty by 2.5% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,387,108 shares of the company’s stock valued at $78,177,000 after purchasing an additional 33,588 shares in the last quarter. Cooper Investors PTY Ltd. grew its stake in shares of Ryan Specialty by 33.9% in the 3rd quarter. Cooper Investors PTY Ltd. now owns 505,374 shares of the company’s stock worth $28,483,000 after buying an additional 127,892 shares in the last quarter. Marshall Wace LLP grew its stake in shares of Ryan Specialty by 142.1% in the 2nd quarter. Marshall Wace LLP now owns 380,116 shares of the company’s stock worth $25,844,000 after buying an additional 223,124 shares in the last quarter. Waters Parkerson & CO. LLC increased its holdings in shares of Ryan Specialty by 4.3% in the 3rd quarter. Waters Parkerson & CO. LLC now owns 508,120 shares of the company’s stock worth $28,638,000 after buying an additional 20,920 shares during the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Ryan Specialty by 56.0% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 68,671 shares of the company’s stock valued at $3,870,000 after buying an additional 24,656 shares in the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

Ryan Specialty Company Profile

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.